ABCB11 p.Arg1153Pro
c.3458G>C · VCV3769191
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9863 | likely pathogenic · top 1% in ABCB11 |
|---|---|---|
| REVEL | 0.967 | strongly pathogenic-leaning |
| SaProt | LLR -17.37 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · C>T here scores Δ0.22 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2.1, phastCons 1 |
| Overall | ||
| CADD | 32.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,458 |
| European (non-Finnish)grpmax | 0.000254% | 393,267 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ABCB11
- Protein
- p.Arg1153Pro
- Coding
- c.3458G>C
- MANE Select
- NM_003742
- Type
- single nucleotide variant
- Location
- chr2:168927316 (GRCh38)
- Gene constraint
- LOEUF 0.739 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 83.23 · 9 PDB
- Residue 1153
- an α-helix; the abc transporter 2 domain; a UniProt-annotated variant site (in pfic2; impairs taurocholate transport activity; significantly reduces protein expression; decreases cell surface protein expression; loss of ell membrane localization)
Disease context
progressive familial intrahepatic cholestasis type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Progressive familial intrahepatic cholestasis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Childhood, Infancy, Neonatal
Similar variants
- ABCB11 p.Arg1153Cys Pathogenic/Likely pathogenic ★★ ⚠ same residue
- ABCB11 p.Arg1153His Pathogenic/Likely pathogenic ★★ same residue
- ABCB11 p.Arg1153Leu Likely pathogenic ★ same residue
- ABCB11 p.Arg1153Gly Uncertain significance ★ ⚠ same residue
- ABCB11 p.Arg1153= Likely benign ★ same residue
- ABCB11 c.1084-2A>G Pathogenic ★★ same condition
- ABCB11 c.1198-1G>C Pathogenic/Likely pathogenic ★★ same condition
- ABCB11 c.1198-2A>C Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/abcb11-p-arg1153pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown